United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,238 | 122,655 | 133,807 | 15,546 | 20,726 |
| Marketable Securities | N/A | N/A | N/A | 132,229 | 43,584 |
| Receivables | 9,940 | 9,659 | 11,789 | 13,191 | 4,451 |
| Inventories | 7,273 | 7,164 | 7,334 | 6,619 | 5,905 |
| Other current assets | 716 | 1,145 | 533 | 325 | 1,921 |
| TOTAL | $110,199 | $141,857 | $155,155 | $169,697 | $77,354 |
| Non-Current Assets | |||||
| PPE Net | 10,384 | 9,120 | 8,585 | 6,731 | 6,709 |
| Investments And Advances | 44,667 | 16,388 | 6,396 | 7,175 | 102,236 |
| Intangibles | 14,558 | 14,466 | 14,674 | 14,903 | 15,135 |
| Other Non-Current Assets | 2,172 | 2,735 | 2,663 | 2,098 | 764 |
| TOTAL | $71,781 | $42,709 | $32,318 | $30,907 | $124,844 |
| Total Assets | $181,980 | $184,566 | $187,473 | $200,604 | $202,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,091 | 111 | 111 | 107 | 104 |
| Accounts payable and accrued liabilities | 2,810 | 2,988 | 3,922 | 5,933 | 3,428 |
| Accrued Expenses | 6,003 | 4,451 | 3,787 | 2,840 | 2,816 |
| Other current liabilities | 46 | 51 | 34 | 31 | 80 |
| TOTAL | $11,045 | $9,307 | $9,796 | $11,054 | $7,928 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,752 | 1,767 | 1,781 | 1,799 | 1,814 |
| Other Non-Current Liabilities | 872 | 1,834 | 1,787 | 1,715 | 1,654 |
| TOTAL | $2,624 | $3,601 | $3,568 | $3,514 | $3,468 |
| Total Liabilities | $13,669 | $12,908 | $13,364 | $14,568 | $11,396 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,205 | 41,848 | 41,837 | 41,795 | 40,456 |
| Common Shares | 215 | 215 | 214 | 214 | 208 |
| Retained earnings | -188,845 | -185,821 | -183,216 | -171,029 | -167,847 |
| Other shareholders' equity | -238 | 134 | 115 | 126 | 126 |
| TOTAL | $168,311 | $171,658 | $174,109 | $186,036 | $190,802 |
| Total Liabilities And Equity | $181,980 | $184,566 | $187,473 | $200,604 | $202,198 |